IBDEI1TX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29227,1,3,0)
 ;;=3^Medication-Induced Parkinsonism,Other
 ;;^UTILITY(U,$J,358.3,29227,1,4,0)
 ;;=4^G21.19
 ;;^UTILITY(U,$J,358.3,29227,2)
 ;;=^5003773
 ;;^UTILITY(U,$J,358.3,29228,0)
 ;;=G21.11^^118^1471^13
 ;;^UTILITY(U,$J,358.3,29228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29228,1,3,0)
 ;;=3^Neuroleptic-Induced Parkinsonism
 ;;^UTILITY(U,$J,358.3,29228,1,4,0)
 ;;=4^G21.11
 ;;^UTILITY(U,$J,358.3,29228,2)
 ;;=^5003772
 ;;^UTILITY(U,$J,358.3,29229,0)
 ;;=G24.01^^118^1471^15
 ;;^UTILITY(U,$J,358.3,29229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29229,1,3,0)
 ;;=3^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,29229,1,4,0)
 ;;=4^G24.01
 ;;^UTILITY(U,$J,358.3,29229,2)
 ;;=^5003784
 ;;^UTILITY(U,$J,358.3,29230,0)
 ;;=G24.09^^118^1471^16
 ;;^UTILITY(U,$J,358.3,29230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29230,1,3,0)
 ;;=3^Tardive Dystonia
 ;;^UTILITY(U,$J,358.3,29230,1,4,0)
 ;;=4^G24.09
 ;;^UTILITY(U,$J,358.3,29230,2)
 ;;=^5003786
 ;;^UTILITY(U,$J,358.3,29231,0)
 ;;=G25.1^^118^1471^11
 ;;^UTILITY(U,$J,358.3,29231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29231,1,3,0)
 ;;=3^Medication-Induced Postural Tremor
 ;;^UTILITY(U,$J,358.3,29231,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,29231,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,29232,0)
 ;;=G25.71^^118^1471^14
 ;;^UTILITY(U,$J,358.3,29232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29232,1,3,0)
 ;;=3^Tardive Akathisia
 ;;^UTILITY(U,$J,358.3,29232,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,29232,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,29233,0)
 ;;=G25.79^^118^1471^9
 ;;^UTILITY(U,$J,358.3,29233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29233,1,3,0)
 ;;=3^Medication-Induced Movement Disorder,Other
 ;;^UTILITY(U,$J,358.3,29233,1,4,0)
 ;;=4^G25.79
 ;;^UTILITY(U,$J,358.3,29233,2)
 ;;=^5003800
 ;;^UTILITY(U,$J,358.3,29234,0)
 ;;=T43.205A^^118^1471^4
 ;;^UTILITY(U,$J,358.3,29234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29234,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
 ;;^UTILITY(U,$J,358.3,29234,1,4,0)
 ;;=4^T43.205A
 ;;^UTILITY(U,$J,358.3,29234,2)
 ;;=^5050540
 ;;^UTILITY(U,$J,358.3,29235,0)
 ;;=T43.205D^^118^1471^5
 ;;^UTILITY(U,$J,358.3,29235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29235,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,29235,1,4,0)
 ;;=4^T43.205D
 ;;^UTILITY(U,$J,358.3,29235,2)
 ;;=^5050541
 ;;^UTILITY(U,$J,358.3,29236,0)
 ;;=T43.205S^^118^1471^6
 ;;^UTILITY(U,$J,358.3,29236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29236,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
 ;;^UTILITY(U,$J,358.3,29236,1,4,0)
 ;;=4^T43.205S
 ;;^UTILITY(U,$J,358.3,29236,2)
 ;;=^5050542
 ;;^UTILITY(U,$J,358.3,29237,0)
 ;;=G25.71^^118^1471^7
 ;;^UTILITY(U,$J,358.3,29237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29237,1,3,0)
 ;;=3^Medication-Induced Acute Akathisia
 ;;^UTILITY(U,$J,358.3,29237,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,29237,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,29238,0)
 ;;=G24.02^^118^1471^8
 ;;^UTILITY(U,$J,358.3,29238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29238,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,29238,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,29238,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,29239,0)
 ;;=G21.0^^118^1471^12
 ;;^UTILITY(U,$J,358.3,29239,1,0)
 ;;=^358.31IA^4^2
